Compare JPMorgan Chase & Co (JPM) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Chase & Co vs Nomura Holdings Inc — how do they compare? JPMorgan Chase & Co trades at $332.99 (market cap $880.98B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: JPMorgan Chase & Co is far larger — about 32× Nomura Holdings Inc's market cap, and Nomura Holdings Inc pays the higher dividend (3.4%). Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Chase & Co for 127 Days and Nomura Holdings Inc for 55 Days on average.
| JPM | NMR | |
|---|---|---|
Market Cap | $880.98B | $27.55B |
Volume | 7,721,661 | 782,470 |
Sector | Financials | Financials |
52-Week High | $365.18 | $10.86 |
52-Week Low | $282.84 | $6.73 |
Typical Hold Time | 127 Days | 55 Days |
Enterprise Value | $1.82T | $38.54T |
Dividend Yield | 1.99% | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPMorgan Chase (JPM) trades at $331.42, up 0.56% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q1 and Q2 2026 earnings beats but missed Q4 2025 expectations. Revenue grew to $181.85B in 2025 with solid profitability metrics including 33.38% net income margin and 18.43% ROE. Analyst consensus remains positive with 52.46% buy ratings and $373.18 price target representing 12.6% upside potential.
JPMorgan demonstrates fundamental strength with consistent revenue growth and industry-leading profitability, though negative cash flow trends and geopolitical risks warrant monitoring. The stock offers value at 14.2 P/E with institutional support, but investors should weigh macroeconomic uncertainties and banking sector volatility against the company's strong market position and dividend yield.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
